Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-a) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-a-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling
Freeman K, Connock M, Auguste P, Taylor-Phillips S, Mistry H, Shyangdan D, et al.
Record ID 32015000739
English
Details
Project Status:
Completed
URL for project:
http://www.journalslibrary.nihr.ac.uk/programmes/hta/146903
Year Published:
2016
URL for published report:
https://www.journalslibrary.nihr.ac.uk/hta/hta20830#/abstract
Requestor:
NIHR Health Technology Assessment programme
URL for additional information:
http://www.nice.org.uk/guidance/indevelopment/gid-dt24
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Enzyme-Linked Immunosorbent Assay
- Tumor Necrosis Factor-alpha
- Antibodies, Monoclonal
- Anti-Inflammatory Agents
- Molecular Diagnostic Techniques
- Crohn Disease
- Monitoring, Ambulatory
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.